Rx-Precision
Precision Medical Management
We improve outcomes and lower costs for high-risk, complex patient populations by personalizing their prescription plan to their DNA
The Problem
The Cost of Non-optimized Prescriptions
Most drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It’s difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. This is especially true for high-cost, high-risk patients with complex chronic disease and polypharmacy.
How Rx-Precision Works
The Rx-Precision Medical Management Platform
Through years of testing, design and application with health plan members, our Precision Medical Management platform has been carefully developed to duplicate the clinical improvements and cost savings in the most impactful precision medicine and genomic research. Our AI-driven precision medical analytics proactively identifies members who will clinically benefit from a genomic intervention and lead to lower costs and then guides the member and their physician through the entire testing and care plan optimization process. Our first solution is PGx-Guided Care.
Our PGx-Guided Care Targets the Costliest and Highest Risk Conditions
Oncology
Cardiovascular
Psychology
Autoimmune
Pain Management
Diabetes
Polypharmacy
Multi-morbidity
PGx-Guided Care™
A NEW PHARMACOGENOMICS CARE DELIVERY MODEL
Pharmacogenomics
Impact Analysis
Our proprietary technology leverages pharmacy, medical and eligibility claims data to identify the population that will clinically benefit from PGx testing and result in lower pharmacy and medical costs
Member Enrollment
Identified members receive education about the intervention via our certified enrollment specialists and are encouraged to participate in the program
Test Selection &
Case Management
Members opting-in are matched to the optimal PGx panel and supported through a clinical genomic case management process. Rx-Precision is PGx Lab agnostic, so we can select the most appropriate panel for each member
Outcomes Reporting
Payors receive comprehensive reports on member participation and satisfaction, post intervention drug-related morbidity and mortality reduction, pharmacy and medical spend reduction ROI. Employers also receive post-intervention data on absenteeism, presenteeism, productivity and stress reduction
Seamless Integration
We work with your existing team to add PGx-Guided Care to your existing strategy
Payor Benefits
Precision Impact Analysis
Analyzes your entire member population to identify and predict which members will clinically benefit from PGx testing
Improves Clinical Outcomes
Improves clinical outcomes for your high-risk, high-cost complex patients
Lower Costs
Potentially lower pharmacy and medical costs for your highest-risk, complex patients
Improves Employee Productivity
Improved employee absenteeism, presenteeism and productivity
Billed as a Medical Claim
Because we contract with payors as a healthcare provider, PGx-Guided Care™ can be billed to your claims fund as a medical claim.
Let’s Get Started
Receive Your Complimentary Pharmacogenomics Impact Analysis for Your Member Population
Read More
For Payors
A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors
The Study
Pharmacogenomic testing and case management for members with complex chronic disease.
The Science
Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations.
2. Lazarou J, Pomeranz BH, Corey PN. JAMA . 1998 Apr 15;279(15):1200-5.
3. Foster, A.J., Murff, H.J., Peterson, J.F. et al. (2003). Ann Intern Med, 2003 Feb 4; 138(3).
4. Spear BB, Health-Chiozzi M, Hu J: Clinical Applications of Pharmacogenetics. Trends Mol. Med. 7, 201-204 (2001)
6. J. Med Econ. 2016;19(3): 213-28 Epub Nov 11, 2015.
7. Plos ONE 12(2): e0170905. https://doi.org10.1371/journal.pone.170905.
8. Sudia, Jason, “Exploring Barriers to the Adoption of Pharmacogenomic Technology in the Clinical Setting by Clinical Healthcare Providers” (2016) 138(3).
Copyright 2019 © Rx-Precision, Inc. All rights reserved.
Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361
Rx-Precision
Precision Medical Management
We improve outcomes and lower costs for high-risk, complex patient populations by personalizing their prescription plan to their DNA
The Problem
The cost of non-optimized prescriptions. Most drugs that are currently available are “one size fits all,” but they don’t work the same way for everyone. It’s difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects. This is especially true for high-cost, high-risk patients with complex chronic disease and polypharmacy.
Our PGx-Guided Care Targets the Costliest and Highest Risk Conditions
Oncology
Pain
Management
Polypharmacy
Diabetes
Cardiovascular
Psychology
Autoimmune
Multi-morbidity
PGx-Guided Care™
Medication Impact Analysis
Member Enrollment
Test Selection & Case Management
Member Counseling & Physician Support
Outcomes Reporting
How it Works
Seamless Integration
We work with your existing team to add PGx-Guided Care to your existing strategy
Our PGx-Guided Care process is designed to integrate seamlessly with existing case management workflows and maximize the clinical and cost outcomes of complex, high-risk members. We understand being on the frontline of patient care and leverage our years of clinical experience in value-based settings to collaborate with the member’s care team.
Payor Benefits
Precision Impact Analysis
Analyzes your entire member population to identify and predict which members will clinically benefit from PGx testing
Improves Clinical Outcomes
Improves clinical outcomes for your high-risk, high-cost complex patients
Lower Costs
Potentially lower pharmacy and medical costs for your highest-risk, complex patients
Improves Employee Productivity
Improved employee absenteeism, presenteeism and productivity
Billed as a Medical Claim
Because we contract with payors as a healthcare provider, PGx-Guided Care™ can be billed to your claims fund as a medical claim.
Let’s Get Started
Receive Your Complimentary Pharmacogenomics Impact Analysis For Your Member Population
Read More
For Payors
A turnkey pharmacogenomics risk management and medication optimization platform for employers, health plans, third-party administrators and other payors
The Study
Pharmacogenomic testing and case management for members with complex chronic disease.
The Science
Numerous clinical studies have documented that PGx testing leads to improved clinical outcomes and significant costs savings in the right patient populations.
2. Lazarou J, Pomeranz BH, Corey PN. JAMA . 1998 Apr 15;279(15):1200-5.
3. Foster, A.J., Murff, H.J., Peterson, J.F. et al. (2003). Ann Intern Med, 2003 Feb 4; 138(3).
4. Spear BB, Health-Chiozzi M, Hu J: Clinical Applications of Pharmacogenetics. Trends Mol. Med. 7, 201-204 (2001)
5. U.S. National Library of Medicine.
6. J. Med Econ. 2016;19(3): 213-28 Epub Nov 11, 2015.
7. Plos ONE 12(2): e0170905. https://doi.org10.1371/journal.pone.170905.
8. Sudia, Jason, “Exploring Barriers to the Adoption of Pharmacogenomic Technology in the Clinical Setting by Clinical Healthcare Providers” (2016) 138(3).
Copyright 2019 © Rx-Precision, Inc. All rights reserved.
Rx-Precision, Inc.
2945 Townsgate Rd.
Suite #200
Westlake Village, CA 91361
As COO, Joshua designed, built and manages our case management operations which includes member enrollment, testing and all activities between the lab, member, genetic counselors and treating physicians.
Dr. Martin Kohn is an expert in health data analytics, health policy and healthcare management. He is an experienced physician, clinical informaticist, and health policy analyst. He was most recently Chief Medical Scientist at Sentrian, which creates predictive analytic systems integrating home monitoring with longitudinal health data for patients with complex chronic diseases. Sentrian identifies patients who are likely to need hospitalization days before they become seriously ill to provide time to intervene and avoid hospitalization. Previously, he was the Chief Medical Scientist for Care Delivery Systems in IBM Research developing analytic tools for healthcare, including the use of the Watson supercomputer.
Oren is an innovator and technologist with deep experience in healthcare, big data and analytics. He has over 20 years’ experience as an entrepreneur and startup leader. Oren has had proven success in leading the creation of new products, businesses and venture-backed portfolios both as an entrepreneur and in partnership with Fortune 500 / Global 1000 companies. Oren is passionate about building transformative solutions and highly effective teams. He has expertise in artificial intelligence, deep learning, and data science across financial services, healthcare, and industrial sectors. Oren’s recent experience includes being Co-Founder and President of Pivotus Ventures, a new breed of enterprise software company focused in the banking industry that recently sold to Kony. Previously he was General Partner and Chief Strategy and Technology officer at FDC, a venture fund and startup foundry based in Orange County, CA. At FDC Oren ran incubation and oversaw technology and strategy across a portfolio of over 20 new ventures created at FDC.
Roni has more 20 years of industry healthcare technology experience in roles as CTO, CIO and CISO at Health Systems, Pharmaceutical, Biotechnology, Payer, Academic, City/State Government and Medical device companies.
As Chief Financial Officer, Shital is responsible for all of the company’s financial functions including accounting, audit, treasury, corporate finance and investor relations. Shital also leads human resource and legal activities. Her career spans more than 15 years of varied experience in financial management, business leadership and corporate strategy for software companies. Prior to joining Rx-Precision, Shital held previous CFO and Management positions at Pivotus Ventures, Maana and Microsoft. Shital earned a Bachelors of Speech Communication from California State University of Fullerton.
Jake has owned and operated family medicine, integrated health, and behavioral health clinics where he saw first hand how clinical solutions and advancements based on precision medicine can change the way we treat disease.
Dean is a healthcare industry veteran and digital health pioneer with more than twenty years of hands-on digital health experience as a startup Founder, CEO, Chief Commercial Officer and VP of Sales. Dean also has experience as a Partner and Advisor for venture capital firms and startup incubators, accelerators and growth foundries.
Tyler Koep, PhD is a Medical Affairs Specialist at OneOme specializing in clinical research and data analytics. Tyler received his PhD from Mayo Graduate School with a focus in Biomedical Sciences in 2014 and completed a post-doctoral fellowship at the University of Minnesota in 2017. Dr. Koep has numerous publications within the field of epidemiology and public health and provides expertise in designing and executing clinical research studies. Further, Dr. Koep offers subject matter expertise across the field of pharmacogenomics, including scientific foundations of drug metabolism, cost-effectiveness of pharmacogenomic testing, and chronic disease applications
Guru is driven to develop and apply deep technology innovations to solve the big challenges, especially in health and education. He is known for his work on Microbiome Analytics, IBM Watson AI, Smarter Cities, Services Innovation, Mobile Computing, and Distributed Systems.
Dr. Bleyl is board-certified in medical genetics with a doctorate degree in human genetics and background experience spanning clinical care, academic research and oversight of clinical services across an integrated health system. Prior to this role, he directed the Clinical Genetics Institute (CGI) for Intermountain Healthcare, where he oversaw provision of genetic services, implementation of genetic testing stewardship and development of a system-wide infrastructure for storage and use of genomic data. Dr. Bleyl maintains an academic affiliation with the University of Utah, where his clinical practice focuses on cardiovascular genetics.